Overview
Hans-peter Horny practices in Munich, Germany. Horny is rated as an Advanced expert by MediFind in the treatment of Hereditary Alpha-Tryptasemia. Their top areas of expertise are Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Hypereosinophilic Syndrome, and Acute Myeloid Leukemia (AML).
Their clinical research consists of co-authoring 111 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Hereditary Alpha-Tryptasemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mast Cell Activation Syndrome (MCAS)
- Systemic Mastocytosis
- Distinguished
- Hypereosinophilic SyndromeHorny isDistinguished. Learn about Hypereosinophilic Syndrome.
- Advanced
- Acute Myeloid Leukemia (AML)
- Hereditary Alpha-Tryptasemia
- LeukemiaHorny isAdvanced. Learn about Leukemia.
- Urticaria PigmentosaHorny isAdvanced. Learn about Urticaria Pigmentosa.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Megakaryoblastic Leukemia
- Acute Promyelocytic LeukemiaHorny isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Soft Tissue SarcomaHorny isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AnaphylaxisHorny isExperienced. Learn about Anaphylaxis.
- Chronic Myelogenous Leukemia (CML)